ArticlePLOS global public health2026
Developing a Naïve Bayes risk classification machine learning algorithm to predict high viral load in a low-resource setting.
Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Access to routine viral load (VL) testing for people living with HIV (PLHIV) remains limited in many low-resource settings. There is a need for pragmatic, data-driven tools that can proactively identify individuals at increased risk of virological failure. This study aimed to identify predictors of high viral load among PLHIV on antiretroviral therapy (ART) and to evaluate the performance of a Naïve Bayes classification algorithm using routinely collected clinical data. We conducted a retrospective case-control study using secondary clinical data from two public ART facilities in Makonde District, Zimbabwe. A total of 530 participants (156 cases with VL ≥ 1000 copies/mL and 374 controls) were included. Logistic regression was used to identify independent predictors of high VL. A Naïve Bayes classification model was developed using significant and clinically relevant predictors. Model performance was evaluated on the development dataset, and sensitivity, specificity, predictive values and overall accuracy were calculated. Independent predictors of high VL included being a child (adjusted OR 6.11, 95% CI: 2.12-9.31), adolescent/young adult (AOR 4.69, 95% CI: 1.83-7.54), single/non-partnered marital status (OR 2.01, 95% CI: 1.02-3.04), nondisclosure of HIV status (OR 2.56, 95% CI: 1.48-4.17), ambulatory functional status (OR 3.09, 95% CI 1.64-5.43), recent weight loss on two consecutive visits (OR 4.48, 95% CI: 2.11-8.03, p < 0.001), and ART duration <5 years (OR 1.78, 95% CI 1.15-2.63). The Naïve Bayes model demonstrated a sensitivity of 78.2% and specificity of 96.5%, indicating that the model may miss approximately one in five individuals (22%) with true high viral load, misclassifying them as low risk. The developed Naïve Bayes algorithm shows potential as a risk classification tool to support prioritization of VL testing in resource-limited settings. However, performance estimates represent apparent (development-only) performance and require validation in independent datasets before implementation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.